These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2412191)

  • 41. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL; Stewart PE; Littell L
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of receptor-selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture.
    Wienrich M; Reuss K; Harting J
    Br J Pharmacol; 1989 Nov; 98(3):914-20. PubMed ID: 2480170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TRH fails to antagonize the acute paralytic effects of intrathecal dynorphin A and substance P antagonists in the rat.
    Martinez-Arizala A; Long JB; Holaday JW
    Brain Res; 1988 Nov; 473(2):385-8. PubMed ID: 2466528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antinociceptive effects in mice after intrathecal injection of 5'-N-ethylcarboxamide adenosine.
    Post C
    Neurosci Lett; 1984 Oct; 51(3):325-30. PubMed ID: 6097841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antinociceptive effect of spinal cholinergic stimulation: interaction with substance P.
    Smith MD; Yang XH; Nha JY; Buccafusco JJ
    Life Sci; 1989; 45(14):1255-61. PubMed ID: 2478855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural assessment as substance P antagonists in mice.
    Sakurada T; Kuwahara H; Sakurada S; Kisara K; Ohba M; Munekata E
    Neuropeptides; 1987 Apr; 9(3):197-206. PubMed ID: 2439938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blockade of intrathecal 5-hydroxytryptamine-induced antinociception in rats by noradrenaline depletion.
    Minor BG; Post C; Archer T
    Neurosci Lett; 1985 Feb; 54(1):39-44. PubMed ID: 2983267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of (D-Pro2, D-Trp7,9)-substance P as an antagonist of substance P responses in the rat central nervous system.
    Salt TE; De Vries GJ; Rodriguez RE; Cahusac PM; Morris R; Hill RG
    Neurosci Lett; 1982 Jun; 30(3):291-5. PubMed ID: 6180363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The action of a substance P antagonist on sympathetic nerve activity in the rat.
    Yusof AP; Coote JH
    Neurosci Lett; 1987 Apr; 75(3):329-33. PubMed ID: 2438597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Centrally-mediated bombesin effects on gastrointestinal motility.
    Porreca F; Burks TF; Koslo RJ
    Life Sci; 1985 Jul; 37(2):125-34. PubMed ID: 2409425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the development of tolerance and potential spinal neurotoxicity after chronic intrathecal carbachol-antinociception in the rat.
    Svensson BA; Sottile A; Gordh T
    Acta Anaesthesiol Scand; 1991 Feb; 35(2):141-7. PubMed ID: 2024563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis.
    Couture R; Gupta A; Kérouac R; Escher E; Regoli D
    Can J Physiol Pharmacol; 1987 Mar; 65(3):412-8. PubMed ID: 2438022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats.
    Suzuki N; Kalso E; Rosenberg PH
    Eur J Pharmacol; 1993 Nov; 249(2):247-50. PubMed ID: 8287909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments.
    Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T
    Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.
    Sakurada T; Yamada T; Tan-no K; Manome Y; Sakurada S; Kisara K; Ohba M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):205-10. PubMed ID: 1717679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.